Psychedelic Compound-Based Drug Stock, Mind Medicine, Up 56% Last Week By: TalkMarkets March 11, 2024 at 14:29 PM EDT The FDA has granted breakthrough designation to Mind Medicine's program for the treatment of generalized anxiety disorder. Read More >> Related Stocks: Atai Life Sciences N.V. COMPASS Pathways Plc - American Depository Shares Gh Research Plc Incannex Healthcare Inc. - Common Stock Mind Medicine Mindmed Inc
